Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT07633691
PHASE1
A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects
Sponsor: Dong-A ST Co., Ltd.
View on ClinicalTrials.gov
Summary
This study will exploratively evaluate the safety, tolerability and pharmacokinetics of DA-5223 compared with DA-5223-R in healthy adult subjects
Official title: An Open-label, Randomized, Single-dose, Two-Cohort, Two-Period, Crossover Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects
Key Details
Gender
All
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2026-06-15
Completion Date
2026-07-05
Last Updated
2026-07-15
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DA-5223-R
once a day
DRUG
DA-5223-F
once a day
DRUG
DA-5223-M
once a day
Locations (1)
Bumin hospital
Gangseo-gu, Seoul, South Korea